Ledger.Open graph →
SEC Form D · filed September 29, 2014

XERIS PHARMACEUTICALS INC

Offering
$14.9M
Sold
$7.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Malcolm C. Persen · South Orange, NJExecThomas Wenz · Calgary, Alberta, CanadaExec · DirectorGino Demichele · Calgary, Alberta, CanadaExecShintaro Yamakami · Tokyo, M0ExecSid Paquette · Toronto, Ontario, CanadaExec · DirectorBradley Mascho · Columbus, OHExecJohn Kinzell · Austin, TXExec · DirectorTimothy Sullivan · Waltham, MADirectorShane Brisbin · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗